Mercy BioAnalytics

Delfi Diagnostics

This company develops blood-based liquid biopsy tests for early cancer detection and treatment monitoring for healthcare providers, health systems, and biopharmaceutical partners.

Epiliquid

This company develops blood-based liquid biopsy tests for early cancer detection and monitoring, serving clinical laboratories and medical practitioners.

Oxford Cancer Analytics

The company develops liquid biopsy blood tests using proteomics and machine learning for early lung cancer detection for healthcare providers and screening programmes.

LiquidCell Dx

This company develops blood-based liquid biopsy tests for tumor microenvironment profiling to help pharmaceutical companies and clinical partners predict cancer therapy responses.

Naveris

This molecular diagnostics company develops and commercialises liquid biopsy tests for the early detection and clinical management of viral-associated cancers for healthcare providers.

Glycanostics

This digital health company develops non-invasive liquid biopsy tests for early-stage cancer detection, serving clinical laboratories, hospitals and oncology professionals.

Foresight Diagnostics

This company develops liquid biopsy tests to detect minimal residual disease in cancer patients for biopharmaceutical companies and healthcare providers.

OXCan

This company develops blood tests using proteomics and machine learning to enable early cancer detection for healthcare providers and patients.